Anavex Life Sciences Corp.

AVXLNASDAQHealthcare● Active

$2.55

$-0.02(-0.78%)

Market Cap$236312983

P/E Ratio—

52W High$13.99

52W Low$2.56

Avg Volume1.4M

Open$2.61

Beta1.12

Insider Trades Ownership Employees

Anavex Life Sciences Corp. (AVXL) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · AVXL · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Anavex Life Sciences Corp. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

AVXL insider buying and selling by quarter

AVXL insider selling · AVXL insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.1M527K0

2023 Q2

2024 Q1

2024 Q2

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · AVXL ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

AVXL executive sell shares · AVXL board member insider trading · AVXL insider trading SEC filing

Showing 29 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Sep 11, 2025	MISSLING CHRISTOPHER U President and CEO · Director	Option	187,500	$5.04	$945K	1,655,213	Form 4
Sep 11, 2025	MISSLING CHRISTOPHER U President and CEO · Director	Other	145,048	$9.58	$1.39M⚡	1,510,165	Form 4
Mar 24, 2025	MISSLING CHRISTOPHER U President and CEO · Director	Option	500,000	$0.92	$460K	1,750,210	Form 4
Mar 24, 2025	MISSLING CHRISTOPHER U President and CEO · Director	Other	282,497	$9.63	$2.72M⚡	1,467,713	Form 4
Jun 14, 2024	Donhauser Peter D.O. Director	Purchase	2,835	$3.64	$10K	5,000	Form 4
May 15, 2024	Thomas Steffen Director	Purchase	5,000	$4.52	$23K	5,000	Form 4
Mar 28, 2024	MISSLING CHRISTOPHER U President and CEO · Director	Option	73,380	$1.32	$97K	1,323,590	Form 4
Mar 28, 2024	MISSLING CHRISTOPHER U President and CEO · Director	Sale	73,380	$5.11	$375K	1,250,210	Form 4
Jun 28, 2023	MISSLING CHRISTOPHER U President and CEO · Director	Option	268,000	$1.60	$429K	1,286,210	Form 4
Jun 29, 2023	MISSLING CHRISTOPHER U President and CEO · Director	Option	232,000	$1.60	$371K	1,250,210	Form 4
Jun 28, 2023	MISSLING CHRISTOPHER U President and CEO · Director	Sale	268,000	$7.98	$2.14M⚡	1,018,210	Form 4
May 25, 2022	Skarpelos Athanasios Director	Sale	50,000	$9.06	$453K	1,306,458	Form 4
Jun 29, 2021	MISSLING CHRISTOPHER U President and CEO · Director	Option	51,620	$1.32	$68K	1,069,830	Form 4
Jun 29, 2021	MISSLING CHRISTOPHER U President and CEO · Director	Sale	51,620	$26.00	$1.34M⚡	1,018,210	Form 4
Jun 29, 2021	Boenisch Sandra PFO and Treasurer	Option	35,000	$5.92	$207K	189,659	Form 4
Jun 29, 2021	Boenisch Sandra PFO and Treasurer	Option	106,696	$3.28	$350K	154,659	Form 4
Jun 29, 2021	Boenisch Sandra PFO and Treasurer	Option	25,000	$5.68	$142K	47,963	Form 4
Jun 29, 2021	Boenisch Sandra PFO and Treasurer	Sale	166,696	$26.53	$4.42M⚡	22,963	Form 4
May 21, 2021	FAVUS ELLIOT Director	Option	50,000	$2.96	$148K	145,000	Form 4
May 21, 2021	FAVUS ELLIOT Director	Option	1,500	$6.11	$9K	95,000	Form 4
May 21, 2021	FAVUS ELLIOT Director	Option	1,500	$5.66	$8K	93,500	Form 4
May 21, 2021	FAVUS ELLIOT Director	Option	1,500	$4.90	$7K	92,000	Form 4
May 21, 2021	FAVUS ELLIOT Director	Option	1,500	$5.57	$8K	90,500	Form 4
May 21, 2021	FAVUS ELLIOT Director	Option	1,500	$5.64	$8K	89,000	Form 4
May 21, 2021	FAVUS ELLIOT Director	Option	50,000	$0.92	$46K	87,500	Form 4

MISSLING CHRISTOPHER U

President and CEO · Director

Option

Date

Sep 11

187,500

Price

$5.04

Value

$945K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Other

Date

Sep 11

145,048

Price

$9.58

Value

$1.39M ⚡

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Option

Date

Mar 24

500,000

Price

$0.92

Value

$460K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Other

Date

Mar 24

282,497

Price

$9.63

Value

$2.72M ⚡

View Form 4 on SEC.gov

Donhauser Peter D.O.

Director

Purchase

Date

Jun 14

2,835

Price

$3.64

Value

$10K

View Form 4 on SEC.gov

Thomas Steffen

Director

Purchase

Date

May 15

5,000

Price

$4.52

Value

$23K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Option

Date

Mar 28

73,380

Price

$1.32

Value

$97K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Sale

Date

Mar 28

73,380

Price

$5.11

Value

$375K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Option

Date

Jun 28

268,000

Price

$1.60

Value

$429K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Option

Date

Jun 29

232,000

Price

$1.60

Value

$371K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Sale

Date

Jun 28

268,000

Price

$7.98

Value

$2.14M ⚡

View Form 4 on SEC.gov

Skarpelos Athanasios

Director

Sale

Date

May 25

50,000

Price

$9.06

Value

$453K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Option

Date

Jun 29

51,620

Price

$1.32

Value

$68K

View Form 4 on SEC.gov

MISSLING CHRISTOPHER U

President and CEO · Director

Sale

Date

Jun 29

51,620

Price

$26.00

Value

$1.34M ⚡

View Form 4 on SEC.gov

Boenisch Sandra

PFO and Treasurer

Option

Date

Jun 29

35,000

Price

$5.92

Value

$207K

View Form 4 on SEC.gov

Boenisch Sandra

PFO and Treasurer

Option

Date

Jun 29

106,696

Price

$3.28

Value

$350K

View Form 4 on SEC.gov

Boenisch Sandra

PFO and Treasurer

Option

Date

Jun 29

25,000

Price

$5.68

Value

$142K

View Form 4 on SEC.gov

Boenisch Sandra

PFO and Treasurer

Sale

Date

Jun 29

166,696

Price

$26.53

Value

$4.42M ⚡

View Form 4 on SEC.gov

FAVUS ELLIOT

Director

Option

Date

May 21

50,000

Price

$2.96

Value

$148K

View Form 4 on SEC.gov

FAVUS ELLIOT

Director

Option

Date

May 21

1,500

Price

$6.11

Value

$9K

View Form 4 on SEC.gov

FAVUS ELLIOT

Director

Option

Date

May 21

1,500

Price

$5.66

Value

$8K

View Form 4 on SEC.gov

FAVUS ELLIOT

Director

Option

Date

May 21

1,500

Price

$4.90

Value

$7K

View Form 4 on SEC.gov

FAVUS ELLIOT

Director

Option

Date

May 21

1,500

Price

$5.57

Value

$8K

View Form 4 on SEC.gov

FAVUS ELLIOT

Director

Option

Date

May 21

1,500

Price

$5.64

Value

$8K

View Form 4 on SEC.gov

FAVUS ELLIOT

Director

Option

Date

May 21

50,000

Price

$0.92

Value

$46K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About AVXL insider trading

AVXL insider trades

Anavex Life Sciences Corp. (AVXL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including MISSLING CHRISTOPHER U (President and CEO · Director). Over the past 12 months, 1 insiders have filed transactions with the SEC. AVXL insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Anavex Life Sciences Corp.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

AVXL insider trading · 5 questions

The insiders of Anavex Life Sciences Corp. (AVXL) include executives and directors such as MISSLING CHRISTOPHER U (President and CEO · Director), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

AVXL board member insider tradingwho are AVXL insidersAVXL insider rosterAnavex Life Sciences Corp. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026